Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01111942 · ClinicalTrials.gov registry record · Early Phase 1

A Pilot Study of Induction Chemotherapy Followed by Surgery for Locally Advanced Resectable Head and Neck Cancer

A Early Phase 1 study, sponsored by Southern Illinois University.

Terminated
Registry status
Early Phase 1
Development phase
4
Enrollment target

NCT01111942 is a Early Phase 1 study that was terminated before completion, run by Southern Illinois University. The registered enrollment target is 4 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01111942, a Early Phase 1 study, was terminated before completion, sponsored by Southern Illinois University.

TERMINATED
Registry status
Early Phase 1
Development phase
4 participants
Enrollment target

Study Summary

This is a non-randomized open-label investigator initiated pilot study comparing follow-up therapy of advanced head and neck cancer subjects initially treated with triple induction chemotherapy. Subjects will receive surgical treatment or combined chemoradiation therapy based on the subject's apparent clinical response. Spared use of radiation therapy for selective patients who have a complete response to induction chemotherapy could improve well being of this patient population without compromising survival.

Interventions

  • OTHER radiation combined with weekly carboplatin
  • PROCEDURE conservation surgery

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2010-02
Est. Completion 2014-01
Phase Early Phase 1

Sponsor

Southern Illinois University

21 total trials

What the Registry Record Tells You About NCT01111942

The ClinicalTrials.gov registry entry for NCT01111942 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Southern Illinois University, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which radiation combined with weekly carboplatin is the first listed.

NCT01111942 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01111942 about?

NCT01111942 is a clinical study titled "A Pilot Study of Induction Chemotherapy Followed by Surgery for Locally Advanced Resectable Head and Neck Cancer". This is a non-randomized open-label investigator initiated pilot study comparing follow-up therapy of advanced head and neck cancer subjects initially treated with triple induction chemotherapy. Subjects will receive surgical treatment or combined chemoradiation therapy based on the subject's appare...

What is the current status of trial NCT01111942?

This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 4 participants. The study started on 2010-02. Estimated completion is 2014-01.

What interventions are being tested in trial NCT01111942?

The interventions under investigation include: radiation combined with weekly carboplatin (OTHER), conservation surgery (PROCEDURE).

Who is sponsoring clinical trial NCT01111942?

This trial is sponsored by Southern Illinois University, which has 21 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.